ACUTUS MEDICAL, INC.

(AFIB)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
1.660 USD    0.00%
08/11ACUTUS MEDICAL : Unaudited Pro Forma Condensed Consolidated Financial Information - Form 8-K/A
PU
08/11ACUTUS MEDICAL, INC. Other Events (form 8-K/A)
AQ
08/11ACUTUS MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Posting Modest Monday Gains

06/27/2022 | 04:14pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ACUTUS MEDICAL, INC. 0.00% 1.66 Delayed Quote.-51.32%
BIONTECH SE 1.11% 160.35 Delayed Quote.-37.80%
EARGO, INC. 19.91% 1.13 Delayed Quote.-77.84%
NASDAQ COMPOSITE 2.09% 13047.19 Real-time Quote.-16.60%
NEUROSENSE THERAPEUTICS LTD. 5.97% 2.13 Delayed Quote.-13.41%
PFIZER, INC. 3.77% 50.11 Delayed Quote.-15.14%
All news about ACUTUS MEDICAL, INC.
08/11ACUTUS MEDICAL : Unaudited Pro Forma Condensed Consolidated Financial Information - Form 8..
PU
08/11ACUTUS MEDICAL, INC. Other Events (form 8-K/A)
AQ
08/11ACUTUS MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and R..
AQ
08/11ACUTUS MEDICAL : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/11TRANSCRIPT : Acutus Medical, Inc., Q2 2022 Earnings Call, Aug 11, 2022
CI
08/11Earnings Flash (AFIB) ACUTUS MEDICAL Reports Q2 Revenue $4.1M, vs. Street Est of $3.97M
MT
08/11Acutus Medical Reports Second Quarter 2022 Financial Results
AQ
08/11Acutus Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months End..
CI
08/02Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
07/29ACUTUS MEDICAL, INC. : Change in Directors or Principal Officers, Financial Statements and..
AQ
More news
Analyst Recommendations on ACUTUS MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 16,3 M - -
Net income 2022 -80,4 M - -
Net Debt 2022 24,4 M - -
P/E ratio 2022 -0,60x
Yield 2022 -
Capitalization 47,1 M 47,1 M -
EV / Sales 2022 4,40x
EV / Sales 2023 2,42x
Nbr of Employees 338
Free-Float 91,7%
Chart ACUTUS MEDICAL, INC.
Duration : Period :
Acutus Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACUTUS MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 1,66 $
Average target price 3,38 $
Spread / Average Target 103%
EPS Revisions
Managers and Directors
David Harrison Roman President, CEO, CFO & Director
R. Scott Huennekens Executive Chairman
Derrick Chou Chief Technology Officer
Rick Kimes Senior Vice President-Operations
David P. Bonita Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ACUTUS MEDICAL, INC.-51.32%47
THERMO FISHER SCIENTIFIC-9.60%236 331
DANAHER CORPORATION-9.50%216 597
INTUITIVE SURGICAL, INC.-33.66%85 125
EDWARDS LIFESCIENCES CORPORATION-19.10%64 970
BOSTON SCIENTIFIC CORPORATION-0.35%60 600